This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: IBM, AON, FOSL, HUM, EMC

Equinix (EQIX) estimates, target raised at Citigroup. Shares of EQIX now seen reaching $150, according to Citigroup. Estimates also increased on favorable revenue growth prospects. Buy rating.

HCA (HCA) estimates, target boosted at Goldman. Shares of HCA now seen reaching $27, according to Goldman Sachs. Estimates also upped, as the company is realizing a lower tax rate. Neutral rating.

HCA estimates, target raised at UBS. Shares of HCA now seen reaching $35, according to UBS. Estimates also increased on strong Q4 estimates. Buy rating.

Health Net (HNT) numbers increased at BMO. HNT estimates were raised through 2013, BMO Capital said. Company has good operating momentum. Market Perform rating and new $39 price target.

Humana (HUM) numbers lowered at Jefferies. Shares of HUM now seen reaching $103, Jefferies said. Estimates also lowered as MCOs have traded poorly following earnings releases this season. Buy rating.

Humana estimates, target reduced at Goldman. Shares of HUM now seen reaching $103, according to Goldman Sachs. Estimates also cut, given the company's new guidance. Buy rating.

NCR (NCR) estimates, target upped at Goldman. NCR estimates were boosted through 2013, Goldman Sachs said. To match the company's new guidance. Buy rating and new $21 price target.

Nielsen Holdings (NLSN) numbers lowered at Citigroup. Shares of NLSN now seen reaching $35, according to Citigroup. Estimates also lowered on tougher FX and D&A expenses. Buy rating.

Nuance Communications (NUAN) target raised at Oppenheimer. Shares of NUAN now seen reaching $34, Oppenheimer said. Expect solid first quarter as iPhone 4S bolsters key divisions. Outperform rating.

SL Green Realty (SLG) numbers raised at UBS. Shares of SLG now seen reaching $85, according to UBS. Estimates also raised on Q4 results and slightly increased leasing assumptions. Buy rating.

Towers Watson (TW) numbers raised at Goldman. shares of TW now seen reaching $68, according to Goldman Sachs. Estimates also increased, as higher organic growth is improving margins. Neutral rating.

USG (USG) estimates, target raised at Goldman. Shares of USG now seen reaching $8, according to Goldman Sachs. Estimates also increased, given a better pricing environment. Sell rating.

Veeco Instruments (VECO) numbers cut at Goldman. VECO estimates were reduced through 2013, Goldman Sachs said. Company has limited visibility. Neutral rating and new $26 price target.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:






Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,265.99 +109.14 0.64%
S&P 500 2,011.36 +9.79 0.49%
NASDAQ 4,593.4250 +31.2360 0.68%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs